<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">Infectious mononucleosis</z:e>(IM) is a primary Epstein-Barr virus (EBV)<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Since heterophil antibody negative IM is common in Japan, EBV antibody(presence of VCA-IgM or anti-EA, high titers of VCA-IgG in the absence of anti-EBNA) is useful for serologic diagnosis of IM </plain></SENT>
<SENT sid="2" pm="."><plain>Although EBV causes the continuous growth of lymphoid cell lines in vitro and causes malignant diseases such as Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C0153392" disease_type="Neoplastic Process" abbrv="">nasopharyngeal cancer</z:e> and malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in immunocompromised patients, IM is usually self-limiting, and after <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e> EBV persists in B cells throughout life without producing symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we studied CD8+ lymphocytes of patients with IM and demonstrate an increase in lymphocytes expressing HLA-DR and CD45RO, increase of intracellular pH, elevated plasma levels of sCD8, indicating activation of the subset </plain></SENT>
<SENT sid="4" pm="."><plain>We also demonstrate activation of CD4+ T lymphocytes and gamma delta T lymphocytes </plain></SENT>
<SENT sid="5" pm="."><plain>Activation of these immune systems in response to EBV is supposed to play an important role in assuring the benign course of IM </plain></SENT>
</text></document>